JPRN-UMIN000013945招募中未知
TS-1+ Oxaliplatin+ Bevacizumab therapy in consideration of OPTIMOX design for metastatic colorectal cancer - SABMOX study
Sapporo Medical University School of Medicine0 个研究点目标入组 45 人开始时间: 2014年5月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Need to drain malignant fluid. 2.With a history of allergic response to Fluorouracil or Levofolinate calcium or Platinium. 3.Pregnant or lactating women or women of childbearing potential. 4.Uncontrolled infection. 5.Evidence of interstinal lung disease, or pulmonary fibrosis. 6.Clinically significant (i.e. active) cardiovascular disease or past or current history (within the last 1 year) of myocardial infarction. 7.Uncontrollable ulcer indigestive tract. 8.Radiological evidence of CNS metastases or brain cancer. 9.Complication of cerebrovascular disease or symptoms within 1 year. 10.Any surgical treatments within 4 weeks. 11.Administering antithrombotic drug within 10 days. Need to administrate or having anti-platelets therapy 12.Multiple primary cancers within 5 years. 13.Other conditions not suitable for this study.
研究者
相似试验
尚未招募
1 期
A phaseI trial of S-1 Oxaliplatin and Bevacizumab in combination with Radiotherapy for Neozdjuvant Therapy of Locally advanced lower rectal cancerResectable lower rectal cancerJPRN-UMIN000006937Tokushima University Hospital Dept. of Digestive and Pediatric Surgery15
已完成
2 期
Treatment using Oxaliplatin and S-1 Adjuvant chemotherapy for Stage III gastric cancer trialGastric cancerJPRN-UMIN000025824Department of Surgery, Kochi Medical School75
已完成
1 期
Combination chemotherapy of TS-1, oxaliplatin and irinotecan (TIROX) for unresectable gastric cancer; a phase I studygastric cancerJPRN-UMIN000030482Osaka Medical College Hospital18
招募中
1 期
Phase I/II study of TS-1 / Oxaliplatin / Cetuximab / Radiation for KRAS wild type locally advanced and recurrent rectal cancer.advanced and recurrent rectal CancerJPRN-UMIN000006304Graduate School of Medicine, Osaka Univesity31
已完成
2 期
S-1 plus Oxaliplatin combination chemotherapy in a stop-and-go fashion for metastatic colorectal cancerJPRN-UMIN000004086Yodogawa Christian Hospital40